ESG

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

Hoth Therapeutics files patents for a therapy to mitigate severe skin reactions from cancer treatments, a strategic move that could transform patient care.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

A price increase on critical specialty chemicals by Trecora reveals mounting cost pressures that could ripple through automotive, construction, and water treatment.

Ironwood Pharma forecasts a massive profit jump by lowering its top drug's price, a bold move as it advances its rare disease pipeline for future growth.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

At CES 2026, PETKIT unveiled an AI ecosystem that turns feeders and litter boxes into health monitors, promising to catch illnesses in pets early.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

Aeromexico repeats as the world's most on-time airline, while Qatar Airways earns top honors for operational excellence in Cirium's 2025 rankings.

Celebrating 25 years, ADATA unveils a future of accessible AI, eco-friendly gear, massive 128GB DDR5 modules, and a new XPG gaming ecosystem.

Supermicro's new liquid-cooled 6U SuperBlade packs 100 servers per rack, powered by Intel Xeon 6900 CPUs to tackle the most demanding AI & HPC workloads.

The Battery Show Asia launches awards to honor women leaders, aiming to close a critical gender gap and unlock innovation in the region's booming energy industry.

Azores Labs launches Jumpo, an AI-powered kids' camera blending creativity and safety. But can it win over parents in a competitive tech market?

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.

A US-based Sikh group proposes a Christian homeland in India, citing a wave of anti-Christian violence that marred Christmas 2025 celebrations.

With platinum prices soaring, junior miner ValOre Metals is pivoting to development at its unique Brazilian project, signaling a potential closing of its valuation gap.

As Aircastle prepares its Q3 2025 results, all eyes are on the leasing giant for insights into the supercharged global aviation finance sector.